Brief CV:
Juan Buela Fernández is Manager at SunRock Biopharma, where he leads the company’s corporate strategy and operational execution. He has more than twenty years of experience in senior management positions within the biotechnology sector. His work focuses on the strategic development of therapeutic antibody programs, the financing of innovative companies, international partnering and licensing transactions, and the management of alliances with universities, research centers, pharmaceutical companies, and investors.
The Business of Not Manufacturing Drugs: How to Become a Recurring Innovation Partner for the Pharmaceutical Industry
Abstract:
Can a biotechnology company build a profitable business without manufacturing or selling drugs? Yes, provided it understands that its true product is not the final drug, but sufficiently differentiated innovation with significant risk reduction, making it attractive for a major pharmaceutical company to incorporate into its pipeline. This presentation will explore how a biotech can become a recurring provider of innovation through a model based on outstanding science, intellectual property, and open innovation. Because, in many cases, the greatest value lies not in commercializing a drug, but in creating the assets that will enable others to do so.
